Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Vinorelbine in Elderly Metastatic Breast Cancer
NCT00022152Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Nov 2001
- Primary completion
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of vinorelbine in breast cancer, sponsored by Cancer and Leukemia Group B. Primary endpoint: Objective Response Rate up to 5 years. Started Nov 2001; status: completed.
02
Drugs
vinorelbine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00022152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00022152.